Insulet Corporation (BIT:1PODD)
Italy flag Italy · Delayed Price · Currency is EUR
285.30
0.00 (0.00%)
Last updated: Jul 15, 2025

Insulet Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.

It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

The company sells its products to end-users through the pharmacy channel; and independent distributors.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
CountryUnited States
Founded2000
IndustryElectromedical and Electrotherapeutic Apparatus
Employees3,900
CEOAshley McEvoy

Contact Details

Address:
100 Nagog Park
Acton, Delaware 01720
United States
Phone978 600 7000
Websiteinsulet.com

Stock Details

Ticker Symbol1PODD
ExchangeBorsa Italiana
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code3845

Key Executives

NamePosition
Ashley McEvoyChief Executive Officer
Ana ChadwickChief Financial Officer
Prem SinghChief Operating Officer
June LazaroffHead of Investor Relations